Insider Trading activities at Regenxbio Inc. (RGNX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regenxbio Inc. (RGNX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regenxbio Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1590877.

Total stock buying since 2015: $3,850,000.
Total stock sales since 2015: $96,318,700.
Total stock option exercises since 2015: $13,594,252.


 1   2 
13 insiders reported insider trading activities at Regenxbio Inc. (RGNX):
Insider trading activities of Simpson Curran
Insider trading activities of Beshar Luke M
Insider trading activities of Deerfield Partners, Lp
Insider trading activities of Danos Olivier
Insider trading activities of Pakola Steve
Insider trading activities of Fmr Llc
Insider trading activities of Christmas Patrick J.
Insider trading activities of Hayden Donald J Jr
Insider trading activities of Fox Allan M.
Insider trading activities of Vasista Vittal
Insider trading activities of Karabelas Argeris N
Insider trading activities of Yoo Stephen
Insider trading activities of Mills Kenneth T.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Regenxbio Inc. (RGNX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 20,602 $163,044 51,354 $193,090
2024 0 $0 198,726 $3,223,285 245,335 $1,199,020
2023 0 $0 48,138 $955,385 80,000 $133,475
2022 0 $0 28,878 $967,578 29,900 $25,415
2021 0 $0 303,884 $12,811,279 120,998 $1,097,833
2020 0 $0 283,502 $13,127,335 167,311 $1,534,207
2019 0 $0 248,238 $12,137,989 369,132 $2,249,954
2018 0 $0 683,586 $39,224,436 861,584 $5,746,581
2017 0 $0 438,479 $11,375,850 332,530 $1,308,427
2016 0 $0 206,752 $2,332,519 125,000 $106,250
2015 175,000 $3,850,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Regenxbio Inc. (RGNX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-05 0 $0 20,602 $163,044 20,602 $77,463
2025-03 0 $0 0 $0 30,752 $115,627
2024-10 0 $0 10,000 $101,050 10,000 $37,600
2024-08 0 $0 10,200 $146,384 46,416 $114,193
2024-07 0 $0 60,648 $839,416 51,000 $290,538
2024-05 0 $0 15,000 $237,225 15,000 $56,400
2024-04 0 $0 15,000 $272,865 15,000 $56,400
2024-03 0 $0 27,878 $693,165 47,919 $418,289
2024-02 0 $0 15,000 $250,170 15,000 $56,400
2024-01 0 $0 45,000 $683,010 45,000 $169,200
2023-12 0 $0 45,000 $885,825 45,000 $103,725
2023-05 0 $0 0 $0 35,000 $29,750
2023-01 0 $0 3,138 $69,560 0 $0
2022-08 0 $0 22,480 $769,616 0 $0
2022-07 0 $0 4,800 $144,030 0 $0
2022-01 0 $0 1,598 $53,932 29,900 $25,415
2021-12 0 $0 112,869 $3,933,299 0 $0
2021-11 0 $0 1,500 $60,000 1,500 $5,640
2021-09 0 $0 87,733 $3,934,512 39,500 $97,595
2021-07 0 $0 0 $0 10,000 $8,500
2021-06 0 $0 6,000 $240,465 6,000 $22,560
2021-02 0 $0 16,001 $744,068 16,001 $193,612
2021-01 0 $0 79,781 $3,898,935 47,997 $769,926
2020-12 0 $0 92,500 $4,126,398 30,500 $25,925

Table 3. Detailed insider trading at Regenxbio Inc. (RGNX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-05-12 Mills Kenneth T. Sale 20,602 7.91 163,044
2025-05-12 Mills Kenneth T. Option Ex 20,602 3.76 77,463
2025-03-27 Mills Kenneth T. Option Ex 30,752 3.76 115,627
2024-10-01 Karabelas Argeris N Sale 10,000 10.11 101,050
2024-10-01 Karabelas Argeris N Option Ex 10,000 3.76 37,600
2024-08-08 Mills Kenneth T. Option Ex 36,316 .85 30,868
2024-08-01 Simpson Curran (Chief Executive Officer) Sale 100 15.00 1,500
2024-08-01 Karabelas Argeris N Sale 10,100 14.35 144,884
2024-08-01 Karabelas Argeris N Option Ex 10,100 8.25 83,325
2024-07-29 Simpson Curran (Chief Executive Officer) Sale 9,648 15.04 145,105
2024-07-29 Karabelas Argeris N Sale 11,000 15.04 165,495
2024-07-29 Karabelas Argeris N Option Ex 11,000 12.74 140,140
2024-07-25 Mills Kenneth T. Sale 15,369 13.96 214,505
2024-07-25 Mills Kenneth T. Option Ex 15,369 3.76 57,787
2024-07-24 Mills Kenneth T. Sale 12,221 13.78 168,429
2024-07-24 Mills Kenneth T. Option Ex 12,221 3.76 45,950
2024-07-17 Mills Kenneth T. Sale 2,210 13.77 30,440
2024-07-17 Mills Kenneth T. Option Ex 2,210 3.76 8,309
2024-07-16 Mills Kenneth T. Sale 200 13.76 2,752
2024-07-16 Mills Kenneth T. Option Ex 200 3.76 752
2024-07-01 Karabelas Argeris N Sale 10,000 11.27 112,690
2024-07-01 Karabelas Argeris N Option Ex 10,000 3.76 37,600
2024-05-14 Mills Kenneth T. (President and CEO) Sale 15,000 15.81 237,225
2024-05-14 Mills Kenneth T. (President and CEO) Option Ex 15,000 3.76 56,400
2024-04-15 Mills Kenneth T. (President and CEO) Sale 15,000 18.19 272,865
2024-04-15 Mills Kenneth T. (President and CEO) Option Ex 15,000 3.76 56,400
2024-03-19 Vasista Vittal (Chief Financial Officer) Option Ex 20,041 3.76 75,354
2024-03-14 Mills Kenneth T. (President and CEO) Sale 15,000 21.86 327,945
2024-03-14 Mills Kenneth T. (President and CEO) Option Ex 15,000 3.76 56,400
2024-03-05 Pakola Steve (Chief Medical Officer) Sale 12,878 28.36 365,220
2024-03-05 Pakola Steve (Chief Medical Officer) Option Ex 12,878 22.25 286,535
2024-02-14 Mills Kenneth T. (President and CEO) Sale 15,000 16.68 250,170
2024-02-14 Mills Kenneth T. (President and CEO) Option Ex 15,000 3.76 56,400
2024-01-16 Mills Kenneth T. (President and CEO) Sale 45,000 15.18 683,010
2024-01-16 Mills Kenneth T. (President and CEO) Option Ex 45,000 3.76 169,200
2023-12-19 Mills Kenneth T. (President and CEO) Sale 45,000 19.68 885,825
2023-12-19 Mills Kenneth T. (President and CEO) Option Ex 45,000 2.31 103,725
2023-05-31 Vasista Vittal (Chief Financial Officer) Option Ex 35,000 .85 29,750
2023-01-03 Pakola Steve (Chief Medical Officer) Sale 3,138 22.17 69,560
2022-08-30 Vasista Vittal (Chief Financial Officer) Sale 2,400 30.24 72,573
2022-08-05 Vasista Vittal (Chief Financial Officer) Sale 17,280 35.19 608,031
2022-08-04 Vasista Vittal (Chief Financial Officer) Sale 400 35.00 14,000
2022-08-01 Vasista Vittal (Chief Financial Officer) Sale 2,400 31.25 75,012
2022-07-14 Vasista Vittal (Chief Financial Officer) Sale 468 30.00 14,040
2022-07-13 Vasista Vittal (Chief Financial Officer) Sale 4,332 30.01 129,990
2022-01-20 Vasista Vittal (Chief Financial Officer) Option Ex 29,900 .85 25,415
2022-01-03 Pakola Steve (Chief Medical Officer) Sale 1,598 33.75 53,932
2021-12-23 Fox Allan M. Sale 51,231 35.38 1,812,706
2021-12-22 Fox Allan M. Sale 61,638 34.40 2,120,593
2021-11-08 Mills Kenneth T. (President and CEO) Sale 1,500 40.00 60,000
2021-11-08 Mills Kenneth T. (President and CEO) Option Ex 1,500 3.76 5,640
2021-09-27 Mills Kenneth T. (President and CEO) Sale 1,500 42.19 63,285
2021-09-27 Mills Kenneth T. (President and CEO) Option Ex 1,500 3.76 5,640
2021-09-17 Fox Allan M. (Director) Sale 48,233 45.04 2,172,317
2021-09-14 Mills Kenneth T. (President and CEO) Sale 35,000 45.11 1,578,850
2021-09-14 Mills Kenneth T. (President and CEO) Option Ex 35,000 2.31 80,675
2021-09-13 Mills Kenneth T. (President and CEO) Sale 3,000 40.02 120,060
2021-09-13 Mills Kenneth T. (President and CEO) Option Ex 3,000 3.76 11,280
2021-07-27 Vasista Vittal (Chief Financial Officer) Option Ex 10,000 .85 8,500
2021-06-25 Mills Kenneth T. (President and CEO) Sale 1,500 40.25 60,375
2021-06-25 Mills Kenneth T. (President and CEO) Option Ex 1,500 3.76 5,640
2021-06-24 Mills Kenneth T. (President and CEO) Sale 4,500 40.02 180,090
2021-06-24 Mills Kenneth T. (President and CEO) Option Ex 4,500 3.76 16,920
2021-02-12 Christmas Patrick J. (Chief Legal Officer) Sale 4,701 49.08 230,725
2021-02-12 Christmas Patrick J. (Chief Legal Officer) Option Ex 4,701 12.10 56,882
2021-02-08 Christmas Patrick J. (Chief Legal Officer) Sale 1,300 49.11 63,843
2021-02-08 Christmas Patrick J. (Chief Legal Officer) Option Ex 1,300 12.10 15,730
2021-02-02 Christmas Patrick J. (Chief Legal Officer) Sale 10,000 44.95 449,500
2021-02-02 Christmas Patrick J. (Chief Legal Officer) Option Ex 10,000 12.10 121,000
2021-01-25 Mills Kenneth T. (President and CEO) Sale 6,500 43.89 285,304
2021-01-25 Mills Kenneth T. (President and CEO) Option Ex 6,500 .85 5,525
2021-01-15 Vasista Vittal (Chief Financial Officer) Sale 252 50.04 12,610
2021-01-14 Vasista Vittal (Chief Financial Officer) Sale 11,093 50.03 554,982
2021-01-14 Simpson Curran (Chief Oper. & Tech. Officer) Sale 11,612 50.01 580,716
2021-01-14 Simpson Curran (Chief Oper. & Tech. Officer) Option Ex 11,612 27.65 321,071
2021-01-12 Vasista Vittal (Chief Financial Officer) Sale 4,200 50.01 210,042
2021-01-12 Christmas Patrick J. (Chief Legal Officer) Sale 1,378 49.15 67,728
2021-01-12 Christmas Patrick J. (Chief Legal Officer) Option Ex 1,378 19.50 26,871
2021-01-12 Simpson Curran (Chief Oper. & Tech. Officer) Sale 1,700 50.03 85,051
2021-01-12 Simpson Curran (Chief Oper. & Tech. Officer) Option Ex 1,700 19.50 33,150
2021-01-11 Christmas Patrick J. (Chief Legal Officer) Sale 10,122 49.08 496,787
2021-01-11 Christmas Patrick J. (Chief Legal Officer) Option Ex 10,122 15.80 159,927
2021-01-08 Vasista Vittal (Chief Financial Officer) Sale 5,241 47.36 248,229
2021-01-08 Christmas Patrick J. (Chief Legal Officer) Sale 10,000 47.33 473,270
2021-01-08 Christmas Patrick J. (Chief Legal Officer) Option Ex 10,000 12.10 121,000
2021-01-07 Vasista Vittal (Chief Financial Officer) Sale 10,998 50.00 549,900
2021-01-07 Mills Kenneth T. (President and CEO) Sale 1,500 50.01 75,015
2021-01-07 Mills Kenneth T. (President and CEO) Option Ex 1,500 .85 1,275
2021-01-07 Simpson Curran (Chief Oper. & Tech. Officer) Sale 5,185 50.01 259,301
2021-01-07 Simpson Curran (Chief Oper. & Tech. Officer) Option Ex 5,185 19.50 101,107
2020-12-28 Mills Kenneth T. (President and CEO) Sale 6,500 48.81 317,297
2020-12-28 Mills Kenneth T. (President and CEO) Option Ex 6,500 .85 5,525
2020-12-24 Vasista Vittal (Chief Financial Officer) Sale 3,376 50.00 168,800
2020-12-23 Vasista Vittal (Chief Financial Officer) Sale 21,124 50.01 1,056,411
2020-12-23 Mills Kenneth T. (President and CEO) Sale 4,500 50.00 225,000
2020-12-23 Mills Kenneth T. (President and CEO) Option Ex 4,500 .85 3,825
2020-12-16 Mills Kenneth T. (President and CEO) Sale 15,000 45.00 675,000
2020-12-16 Mills Kenneth T. (President and CEO) Option Ex 15,000 .85 12,750
2020-12-11 Vasista Vittal (Chief Financial Officer) Sale 14,916 40.17 599,175
2020-12-10 Vasista Vittal (Chief Financial Officer) Sale 22,584 40.06 904,715
2020-12-10 Mills Kenneth T. (President and CEO) Sale 4,500 40.00 180,000
2020-12-10 Mills Kenneth T. (President and CEO) Option Ex 4,500 .85 3,825
2020-07-15 Vasista Vittal (Chief Financial Officer) Sale 14,950 40.10 599,495
2020-07-15 Vasista Vittal (Chief Financial Officer) Option Ex 3,259 13.09 42,660
2020-05-11 Vasista Vittal (Chief Financial Officer) Sale 500 40.00 20,000
2020-05-11 Vasista Vittal (Chief Financial Officer) Option Ex 500 13.09 6,545
2020-05-08 Vasista Vittal (Chief Financial Officer) Sale 7,000 40.18 281,260
2020-05-08 Vasista Vittal (Chief Financial Officer) Option Ex 2,500 13.09 32,725
2020-04-24 Vasista Vittal (Chief Financial Officer) Sale 12,000 40.11 481,320
2020-04-24 Vasista Vittal (Chief Financial Officer) Option Ex 3,000 13.09 39,270
2020-04-23 Vasista Vittal (Chief Financial Officer) Sale 3,000 40.00 120,000
2020-04-23 Vasista Vittal (Chief Financial Officer) Option Ex 3,000 13.09 39,270
2020-03-31 Vasista Vittal (Chief Financial Officer) Option Ex 10,000 .85 8,500
2020-02-11 Simpson Curran (SVP, Product Development & CTO) Sale 12,564 50.75 637,623
2020-02-11 Simpson Curran (SVP, Product Development & CTO) Option Ex 6,633 22.00 145,926
2020-02-10 Vasista Vittal (Chief Financial Officer) Sale 14,806 49.59 734,155
2020-02-10 Vasista Vittal (Chief Financial Officer) Option Ex 3,000 13.09 39,270
2020-02-10 Simpson Curran (SVP, Product Development & CTO) Sale 44,429 50.22 2,231,224
2020-02-10 Simpson Curran (SVP, Product Development & CTO) Option Ex 31,660 25.77 815,783
2020-02-10 Hayden Donald J Jr Sale 24,800 50.11 1,242,728
2020-02-10 Hayden Donald J Jr Option Ex 24,800 .85 21,080
2020-02-05 Vasista Vittal (Chief Financial Officer) Sale 300 50.00 15,000
2020-02-05 Simpson Curran (SVP, Product Development & CTO) Sale 5,637 50.00 281,850
2020-02-05 Simpson Curran (SVP, Product Development & CTO) Option Ex 5,137 22.60 116,085
2020-02-05 Hayden Donald J Jr Sale 2,000 50.00 100,000
2020-02-05 Hayden Donald J Jr Option Ex 2,000 .85 1,700
2020-01-17 Vasista Vittal (Chief Financial Officer) Sale 2,394 50.00 119,700
2020-01-17 Simpson Curran (SVP, Product Development & CTO) Sale 5,922 50.00 296,100
2020-01-17 Simpson Curran (SVP, Product Development & CTO) Option Ex 5,122 25.77 131,978
2020-01-17 Hayden Donald J Jr Sale 3,200 50.01 160,032
2020-01-17 Hayden Donald J Jr Option Ex 3,200 .85 2,720
2020-01-14 Hayden Donald J Jr Sale 30,000 45.60 1,368,000
2020-01-14 Hayden Donald J Jr Option Ex 30,000 .85 25,500
2020-01-08 Vasista Vittal (Chief Financial Officer) Sale 7,500 41.66 312,450
2020-01-08 Vasista Vittal (Chief Financial Officer) Option Ex 3,000 13.09 39,270
2019-12-09 Simpson Curran (SVP, Product Development & CTO) Sale 15,552 43.83 681,644
2019-09-19 Mills Kenneth T. (President and CEO) Sale 10,000 39.55 395,500
2019-09-19 Mills Kenneth T. (President and CEO) Option Ex 5,000 .85 4,250
2019-09-12 Christmas Patrick J. (SVP, General Counsel) Sale 5,486 42.00 230,412
2019-09-12 Christmas Patrick J. (SVP, General Counsel) Option Ex 5,000 12.10 60,500
2019-08-19 Mills Kenneth T. (President and CEO) Sale 15,000 37.73 565,950
2019-08-19 Mills Kenneth T. (President and CEO) Option Ex 15,000 .85 12,750
2019-07-19 Mills Kenneth T. (President and CEO) Sale 15,000 49.69 745,275
2019-07-19 Mills Kenneth T. (President and CEO) Option Ex 15,000 .85 12,750
2019-07-19 Christmas Patrick J. (SVP, General Counsel) Sale 4,900 50.03 245,147
2019-07-19 Christmas Patrick J. (SVP, General Counsel) Option Ex 4,900 19.50 95,550
2019-07-18 Christmas Patrick J. (SVP, General Counsel) Sale 100 50.00 5,000
2019-07-18 Christmas Patrick J. (SVP, General Counsel) Option Ex 100 19.50 1,950
2019-06-19 Mills Kenneth T. (President and CEO) Sale 15,000 52.76 791,400
2019-06-19 Mills Kenneth T. (President and CEO) Option Ex 15,000 .85 12,750
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of RGNX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regenxbio Inc. (symbol RGNX, CIK number 1590877) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.